Drug Content Measurement
Drug Content Measurement - Related Videos
03:57
Sulforhodamine B Assay: A Sensitive Assay to Measure Drug Resistance Via Determination of Cellular Protein Content in Cancer Cells
0 Views •
2023
This video describes the high throughput colorimetric screening assay, sulforhodamine B assay, to measure drug-induced cytotoxicity in cancer cells. The assay determines the drug resistance by measuring the cell density based on the cellular protein content.
09:24
Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products
0 Views •
Cited by 2 •
2017
A simple and non-destructive technique that measures the average content of drug substances in formulated drug products containing fluorine using low-field fluorine-19 (19F) time-domain (TD) nuclear magnetic resonance (NMR) is presented here. The technique can be applied to the development and manufacturing of drugs in the pharmaceutical industry.
01:23
Measurement of Air Content in Concrete
0 Views •
2024
Air content measurement in concrete is critical for ensuring structural integrity and durability of concrete structures, especially in environments prone to severe weather conditions. Accurate air content analysis optimizes concrete's resistance to freeze-thaw cycles and enhances its workability and strength. Several methods are standardized under ASTM guidelines to measure the air content in fresh concrete, each suitable for different concrete types and conditions. The pressure method,...
07:50
Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
0 Views •
Cited by 39 •
2012
Here we describe a novel high-content chemically induced inflammation assay aiming at the identification of immune-modulatory bioactives. We have successfully combined automated microscopy with custom developed software scripts enabling automated quantification of the inflammatory response as well as further data processing, analysis, mining, and storage.
07:12
A Colorimetric Method for Measuring Iron Content in Plants
0 Views •
Cited by 3 •
2018
We present a simple and reliable protocol for measuring iron content in plant tissues using the colorimetric Prussian Blue method.
FAQs
Calibration connects the analytical signal produced by a sample with a known amount of active pharmaceutical ingredient. Analysts compare the sample response with responses from calibrated reference standards, then use that relationship to calculate concentration. This approach converts an instrument measurement into a quantitative result that can be evaluated against product specifications for potency and labeling accuracy.
The methods differ in how they generate useful analytical signals. High-performance liquid chromatography separates components before detection, whereas ultraviolet-visible spectroscopy detects suitable components through their optical response, and mass spectrometry measures signals associated with the analyzed material. Selecting among these approaches depends on how effectively the formulation components can be separated or detected for the intended measurement.
A representative sample helps ensure that the portion analyzed reflects the drug substance or formulation as a whole. If the sample does not reflect the broader material, the calculated concentration may suggest variability that is limited to the portion tested or may overlook it entirely. Representative preparation therefore supports meaningful evaluations of content uniformity and product quality.
The workflow begins with preparation of a representative sample, followed by separation or detection of its components using an appropriate analytical method. Analysts compare the resulting signal with calibrated reference standards and calculate the active pharmaceutical ingredient concentration. The measured value can then be assessed against product specifications, creating a documented basis for quality-control decisions.
This measurement supports several stages rather than a single test point. It can be applied during pharmaceutical development, manufacturing, product release testing, and stability studies. Across these settings, the results help determine whether the formulation contains the intended amount of active ingredient and whether manufacturing or storage conditions are associated with unacceptable variability or change.
Unexpected results can indicate that the active pharmaceutical ingredient has changed during storage or that the formulation is not sufficiently consistent. Stability studies may reveal declining content associated with degradation, while testing across a product can expose formulation variability or poor content uniformity. These findings help connect analytical measurements with product performance and compliance assessment.